Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy [0.03%]
自身免疫性星形胶质细胞病的临床过程和长期预后
Joaquín Arzalluz-Luque,Pauline Dumez,Géraldine Picard et al.
Joaquín Arzalluz-Luque et al.
Background: The aim was to describe the clinical course and long-term outcomes of the French cohort of patients with glial fibrillary acidic protein (GFAP) astrocytopathy. ...
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis [0.03%]
多发性硬化症抑郁和焦虑的小脑-topography
Federica Giofrè,Alessandra Lugaresi,Flavia Baccari et al.
Federica Giofrè et al.
Background: Depression and anxiety are highly prevalent in multiple sclerosis and significantly impact patient outcomes. However, their link to specific areas of demyelination remains unclear. ...
Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review [0.03%]
遗传性转甲状腺素蛋白淀粉样变性的认知表现和大脑完整性：系统评价
Iara Senem,Rodrigo Melo Conde,Maria Paula Foss et al.
Iara Senem et al.
Background: Central Nervous System involvement in hereditary transthyretin amyloidosis (ATTRv) is present in liver transplanted patients with longstanding ATTRV30M amyloidosis, and in some rarer variants. The pathophysiol...
Association between vascular risk factors burden and neurodegenerative diseases: results from ONDRI [0.03%]
血管危险因素与神经退行性疾病之间的关系：来自ONDRI的结果
Manuel Montero-Odasso,Frederico Pieruccini-Faria,Sandra E Black et al.
Manuel Montero-Odasso et al.
Background: Vascular risk factors are common in older adults and contribute to brain damage, can manifest as increased white matter hyperintensities (WMH), and associated with future risk of stroke and dementia. However, ...
Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review [0.03%]
抗人T细胞CD20单克隆抗体利妥昔单抗治疗谷氨酸脱羧酶自身抗体阳性僵人综合征系统性回顾
Antonia Pignolo,Claudia Vinciguerra,Roberto Monastero et al.
Antonia Pignolo et al.
Background: Stiff-person syndrome (SPS) is a rare autoimmune neurological disorder characterized by muscle rigidity and painful spasms, predominantly affecting young women. It is often associated with high titers of anti-...
Patients' experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson's disease [0.03%]
帕金森病患者长期使用左旋卡比多巴/卡比多巴连续皮下输注的体验和观点
Michael Soileau,Rajeev Kumar,Ashwini Parab et al.
Michael Soileau et al.
Objectives: We aimed to assess ease of use, convenience, self-efficacy, and satisfaction with long-term use of foslevodopa/foscarbidopa (LDp/CDp), a 24-h continuous subcutaneous infusion therapy delivered via an external ...
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis [0.03%]
奥齐生坦治疗多发性硬化症患者的现实世界感染观察研究
Laura Davies,Rasheed Shehadeh,W John Watkins et al.
Laura Davies et al.
Background: Anti-CD20 monoclonal antibodies are now a common first-line treatment for multiple sclerosis (MS). Rituximab, ocrelizumab and ofatumumab have all been associated with a dose-dependent risk of hypogammaglobulin...
Observational Study
Journal of neurology. 2025 May 22;272(6):415. DOI:10.1007/s00415-025-13133-w 2025
Perioperative management of subcutaneous foslevodopa/foscarbidopa: a case report [0.03%]
术前术后使用左旋多巴/卡比多巴缓释剂治疗病例报告
Samir Abu-Rumeileh,Markus Otto,Michael Bucher et al.
Samir Abu-Rumeileh et al.
The gut-brain axis in early Parkinson's disease: from prodrome to prevention [0.03%]
帕金森病的肠-脑轴：从前驱期到预防措施
Patrick James Oliver,Livia Civitelli,Michele T Hu
Patrick James Oliver
Parkinson's disease is the second most common neurodegenerative disorder and fastest growing neurological condition worldwide, yet its etiology and progression remain poorly understood. This disorder is characterized pathologically by the p...
Inconsistent primary motor cortex glucose hypometabolism in primary lateral sclerosis [0.03%]
原发性侧索硬化症患者初级运动皮层葡萄糖代谢异常
Annaliis Lehto,Julia Schumacher,Jens Kurth et al.
Annaliis Lehto et al.
Objective: Primary lateral sclerosis (PLS) is a rare neurodegenerative disorder and a model for upper motor neuron degeneration, which is believed to begin in the primary motor cortex. However, clinical observation sugges...